The Initial Public Offer (IPO) of Tatva Chintan has been in huge demand among investors including financial institutions, retail individuals, and others. This IPO recorded a massive subscription of 180.6 times and recently it has been updated by the company that the allotment of shares in the IPO is certainly to be settled on 26th July 2021. Moreover, the shares will be listed in the National Stock Exchange (NSE) as well as on the Bombay Stock Exchange (BSE). The size of the IPO is reported to be around Rs. 500 crores, thus, the concerned investors can check their application status by visiting the registrar website.
Tatva Chintan IPO Share Allotment Status
Tatva Chintan is regarded as one the biggest and also the only industrial producer of Structure directing agents (SDAs), Pharmaceutical and agrochemical intermediates, Phase Transfer Catalysts (PTCs), and other speciality chemicals for zeolites in India. Moreover, the company also has the second-largest rank worldwide. Besides, at the global level, the company is one of the leading manufactures of a whole range of PTCs.
Moreover, the company’s business is not only limited to India but as matter of fact, it exports to more than 25 countries globally including, SouthAfrica, UK, the USA, Germany and China. Meanwhile, they have a vast range of clients from various industries including petroleum, automotive, dyes and pigments, medication, agrochemicals, personal care and others.
Tatva Chintan IPO Details
- Opening Date: 16th July 2021
- Closing Date: 20th July 2021
- Face Value (FV): Rs. 10/equity share
- Price (Fixed): Rs. 1073 to Rs. 1083/ equity share
- Size of Lot: 13 shares
- Listed: NSE, BSE
- Listing Date: 29th July 2021
- Issue Size: Rs. 500 Cr (@Rs.10 per share)
- Fresh Issue: Rs. 225 Cr (@Rs.10per share)
- Offer for Sale: 275 crore Eq Shares @ Rs. 10
The IPO size of Tatva Chintan is reported to be Rs. 500 crore, containing a fresh issue of Rs. 225 Crore and an offer sale of 275 crore equity shares at the price of Rs. 10 each. The shares of the company will get listed on 29th July 2021, that is, on Thursday in the NSE as well as on BSE. The process from the fresh issue will be used by the company on manufacturing expansion, and also on the upscaling of the R&D department and general corporate purpose.
Company’s Financials
For the year ended 31st Match 2021 (FY 2021), the company recorded a net profit of Rs. 52.26 crore accompanied by revenue of Rs. 300.35 crore, and total assets of Rs. 314.80 crore.
- Total Assets: Rs. 314.80 crore
- Total Revenue: Rs. Rs. 300.35 crore
- EAT (Earings After Tax): Rs. Rs. 52.26 crore
- D/E Ratio: 0.54
- ROE: 32%
- P/E Ratio: 46%
Tatva Chintan IPO Subscription Details: How to Check Subscription Status
The below mentioned are the category-wise subscription status of the company. According to the latest reports of the company, the IPO of Tatva Chintan Pharma has recorded 180.36 times subscription.
- Qualified Institutional:- 185.23 Times
- Non-Institutional:- 512.22 Times
- Retail Individual:- 35.35 Times
- Employee:- N/A
- Others:- N/A
- Total:- 180.36 Times
The Qualified institutional segment was subscribed 185.23 times, while the Non-institutional investors 512.22 times and retail segment buyers subscribed 35.55 times. The concerned investors who have applied for the shares of Tatva Chintan can visit the official website of its registrar in order to check the allotment status of the company. On successful allotment, the investors will be to track their application status on the website of NSE and BSE. Stay tuned with us.
